Detalles de la búsqueda
1.
Respiratory Syncytial Virus Prefusion F Protein Vaccine in Older Adults.
N Engl J Med
; 388(7): 595-608, 2023 02 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-36791160
2.
Safety and Immunogenicity of a Revaccination With a Respiratory Syncytial Virus Prefusion F Vaccine in Older Adults: A Phase 2b Study.
J Infect Dis
; 229(2): 355-366, 2024 Feb 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-37699064
3.
Respiratory Syncytial Virus Prefusion F Protein Vaccine Is Efficacious in Older Adults With Underlying Medical Conditions.
Clin Infect Dis
; 78(1): 202-209, 2024 01 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-37698366
4.
Efficacy and safety of respiratory syncytial virus prefusion F protein vaccine (RSVPreF3 OA) in older adults over 2 RSV seasons.
Clin Infect Dis
; 2024 Jan 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-38253338
5.
Safety and Immunogenicity of a Respiratory Syncytial Virus Prefusion F (RSVPreF3) Candidate Vaccine in Older Adults: Phase 1/2 Randomized Clinical Trial.
J Infect Dis
; 227(6): 761-772, 2023 03 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-35904987
6.
Safety and Immunogenicity of 3 Formulations of an Investigational Respiratory Syncytial Virus Vaccine in Nonpregnant Women: Results From 2 Phase 2 Trials.
J Infect Dis
; 217(10): 1616-1625, 2018 04 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-29401325
7.
Efficacy of fewer than three doses of an HPV-16/18 AS04-adjuvanted vaccine: combined analysis of data from the Costa Rica Vaccine and PATRICIA Trials.
Lancet Oncol
; 16(7): 775-86, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-26071347
8.
Efficacy, safety, and immunogenicity of the human papillomavirus 16/18 AS04-adjuvanted vaccine in women older than 25 years: 4-year interim follow-up of the phase 3, double-blind, randomised controlled VIVIANE study.
Lancet
; 384(9961): 2213-27, 2014 Dec 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-25189358
9.
Efficacy, immunogenicity and safety of the HPV-16/18 AS04-adjuvanted vaccine in healthy Chinese women aged 18-25 years: results from a randomized controlled trial.
Int J Cancer
; 135(11): 2612-22, 2014 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-24740596
10.
Pooled analysis of large and long-term safety data from the human papillomavirus-16/18-AS04-adjuvanted vaccine clinical trial programme.
Pharmacoepidemiol Drug Saf
; 23(5): 466-79, 2014 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-24644063
11.
Efficacy of the HPV-16/18 AS04-adjuvanted vaccine against low-risk HPV types (PATRICIA randomized trial): an unexpected observation.
J Infect Dis
; 208(9): 1391-6, 2013 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-24092907
12.
Lot-to-lot immunogenicity consistency of the respiratory syncytial virus prefusion F protein vaccine in older adults.
Vaccine X
; 18: 100494, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38746060
13.
Model-based estimates of long-term persistence of induced HPV antibodies: a flexible subject-specific approach.
J Biopharm Stat
; 23(6): 1228-48, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-24138429
14.
Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial.
Lancet Oncol
; 13(1): 89-99, 2012 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-22075171
15.
Safety and immunogenicity of a respiratory syncytial virus prefusion F protein (RSVPreF3) candidate vaccine in older Japanese adults: A phase I, randomized, observer-blind clinical trial.
Respir Investig
; 61(2): 261-269, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-36641341
16.
The RSVPreF3-AS01 vaccine elicits broad neutralization of contemporary and antigenically distant respiratory syncytial virus strains.
Sci Transl Med
; 15(710): eadg6050, 2023 08 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-37611082
17.
Leveraging Influenza Virus Surveillance From 2012 to 2015 to Characterize the Burden of Respiratory Syncytial Virus Disease in Canadian Adults ≥50 Years of Age Hospitalized With Acute Respiratory Illness.
Open Forum Infect Dis
; 10(7): ofad315, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-37441353
18.
Reactogenicity, safety, and immunogenicity of chimeric haemagglutinin influenza split-virion vaccines, adjuvanted with AS01 or AS03 or non-adjuvanted: a phase 1-2 randomised controlled trial.
Lancet Infect Dis
; 22(7): 1062-1075, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35461522
19.
Fewer than three doses of HPV vaccine - Authors' reply.
Lancet Oncol
; 16(9): e424-e425, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-26370346
20.
Safety and efficacy of a recombinant hepatitis E vaccine.
N Engl J Med
; 356(9): 895-903, 2007 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-17329696